Search by Drug Name or NDC
NDC 00024-5761-05 Soliqua 100/33 100; 33 U/mL; ug/mL Details
Soliqua 100/33 100; 33 U/mL; ug/mL
Soliqua 100/33 is a SUBCUTANEOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by sanofi-aventis U.S. LLC. The primary component is INSULIN GLARGINE; LIXISENATIDE.
Product Information
| NDC | 00024-5761 |
|---|---|
| Product ID | 0024-5761_6c6933a6-cede-46c0-8140-7b59797b03d2 |
| Associated GPIs | 2799100235D220 |
| GCN Sequence Number | 076864 |
| GCN Sequence Number Description | insulin glargine/lixisenatide INSULN PEN 100-33/ML SUBCUT |
| HIC3 | C4X |
| HIC3 Description | ANTIHYPERGLY,INSULIN,LONG ACT-GLP-1 RECEPT.AGONIST |
| GCN | 42676 |
| HICL Sequence Number | 043944 |
| HICL Sequence Number Description | INSULIN GLARGINE,HUMAN RECOMBINANT ANALOG/LIXISENATIDE |
| Brand/Generic | Brand |
| Proprietary Name | Soliqua 100/33 |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | insulin glargine and lixisenatide |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | SUBCUTANEOUS |
| Active Ingredient Strength | 100; 33 |
| Active Ingredient Units | U/mL; ug/mL |
| Substance Name | INSULIN GLARGINE; LIXISENATIDE |
| Labeler Name | sanofi-aventis U.S. LLC |
| Pharmaceutical Class | GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA], Insulin Analog [EPC], Insulin [CS] |
| DEA Schedule | n/a |
| Marketing Category | BLA |
| Application Number | BLA208673 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00024-5761-05 (00024576105)
| NDC Package Code | 0024-5761-05 |
|---|---|
| Billing NDC | 00024576105 |
| Package | 5 SYRINGE in 1 CARTON (0024-5761-05) / 3 mL in 1 SYRINGE (0024-5761-02) |
| Marketing Start Date | 2016-11-21 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 56.9753 |
| Pricing Unit | ML |
| Effective Date | 2024-01-03 |
| NDC Description | SOLIQUA 100 UNIT-33 MCG/ML PEN |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 4, 5 |
| Classification for Rate Setting | B |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis